News – Page 516
-
News
Non-metal-catalysed C-C coupling
Chemists in China couple aromatic molecules with an organocatalyst and no transition metal
-
News
Light-rechargeable batteries
Chemists develop new molecular system that can both generate and store charge by light
-
News
Facelift for FutureGren project
US flagship clean coal project morphs into repowering programme with $1 billion in economic stimulus funds
-
News
Nanoparticles and ultrasound team up to treat tumours
New treatment uses magnetic nanoparticles and focused ultrasound to get drugs across the blood-brain barrier
-
News
Microfinancing to solve academic poverty?
Could thousands of small donations from the public for specific projects be the way to fund research in these cash-strapped times?
-
News
Testing nanotube toxicity
A mouse study looking at carbon nanotubes and reproduction suggests that ill-effects are reversible and fertility is not affected
-
-
News
Nitrogenase to be a two-trick pony
A nitrogen-fixing enzyme has shocked scientists by being able to use carbon monoxide as a substrate to make a range of carbon-based products
-
News
Full steam ahead for Iter
Iter, the international nuclear fusion project, has secured European funding, but its new director will be keeping tight hold of the purse strings
-
News
Oil spill poses challenges to China's environment
While BP deals with the aftermath of the biggest accidental oil spill in history, China has been struggling with its first large-scale oil spill
-
News
Magnetic foam bends and stretches
Researchers make magnetic foams and flexible magnetic gel sheets using a cellulose scaffold and magnetic nanoparticles
-
News
Snapshots of mystery molecular structures
Researchers use atomic force microscopy to produce clear molecular images and help determine the correct atomic structure of unknown molecules
-
News
Methane all lined-up
The direction methane molecules are vibrating when they hit a nickel surface can have a huge effect on their reactivity
-
Business
Business roundup: August 2010
Bittersweet victory for GSK’s Avandia GlaxoSmithKline (GSK) has received a muted ’thumbs up’ from a US regulatory advisory panel for its much-maligned Type 2 diabetes drug Avandia (rosiglitazone), making it likely the US Food and Drug Administration (FDA) will allow the UK-based pharma giant to continue selling the drug in ...
-
News
Bubble powered microengines push forward
Enzyme-powered engines pack in the power with peroxide munching microjets